SCHEMBL5019780

SCHEMBL5019780

CC1(C)OB(c2cccc3c2oc2ccccc23)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP2C19 P33261 1/20 0.46
PGR P06401 1/20 0.40
ALOX5 P09917 3/20 0.38
LPL P06858 3/20 0.38
LIPG Q9Y5X9 3/20 0.38
AHR P35869 3/20 0.36
MAOA P21397 3/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
DRD4 P21917 1/20 0.35
JAK2 O60674 1/20 0.34
BTK Q06187 1/20 0.34
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21339756 0.95 MEN1 (0.43) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL26863064 0.95 MEN1 (0.43) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL21204178 0.93 MEN1 (0.41) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL22135457 0.93 ALOX5 (0.46) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL21204181 0.92 MAOA (0.43) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL24071860 0.91 MEN1 (0.38) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL31130282 0.91 MEN1 (0.44) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL22698059 0.91 MEN1 (0.44) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL21975358 0.90 MEN1 (0.39) MEN1KMT2ACYP2C19PGRALOX5
SCHEMBL22135393 0.89 ALOX5 (0.39) MEN1KMT2ACYP2C19PGRALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894542-A Synthetic method of dibenzo [ B, D ] furan-4-boronic acid pinacol ester 郑州海阔光电材料有限公司 2023-04-04 CN claimed
CN-115181095-A Pyrimidine-based luminophor with fluorescence-delayed fluorescence-room temperature phosphorescence triple emission characteristics and preparation method thereof 天津大学 2022-10-14 CN claimed
US-20250241199-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2025-07-24 US disclosed
WO-2025075448-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2025-04-10 WO disclosed
US-20250120304-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2025-04-10 US disclosed
US-20240260455-A1 CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2024-08-01 US disclosed
US-20240239754-A1 PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GUANGDONG UNIVERSITY OF TECHNOLOGY (CN) 2024-07-18 US disclosed
US-20240239754-A1 PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GUANGDONG UNIVERSITY OF TECHNOLOGY (CN) 2024-07-18 US disclosed
WO-2024144246-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2024-07-04 WO disclosed
US-12022729-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-06-25 US disclosed
US-12022729-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-06-25 US disclosed
US-20130099208-A1 CONDENSED-CYCLIC COMPOUND, METHOD FOR PREPARING THE CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED-CYCLIC COMPOUND SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-25 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130037790-A1 NOVEL 10,10-DIALKYLANTHRONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-14 US disclosed
US-20130037790-A1 NOVEL 10,10-DIALKYLANTHRONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-14 US disclosed
WO-2012130709-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-10-04 WO disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 US disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 US disclosed
WO-2012063751-A1 THIOXANTHONE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications EIF4A1, ITPR2, ITPR1 MEN1 1068/4885KMT2A 811/4885CYP2C19 144/4885
US-20130099208-A1 CONDENSED-CYCLIC COMPOUND, METHOD FOR PREPARING THE CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED-CYCLIC COMPOUND C1R, CRY1, C9 MEN1 433/4885KMT2A 1804/4885CYP2C19 1183/4885
US-12022729-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof PIEZO1, VDAC2, ORAI2 MEN1 1441/4885KMT2A 514/4885CYP2C19 1721/4885
US-20240239754-A1 PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF PAH, HTR3D, CYP3A4 MEN1 3312/4885KMT2A 1185/4885CYP2C19 18/4885
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 MEN1 1652/4885KMT2A 3714/4885CYP2C19 82/4885
US-20240260455-A1 CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT SLC43A1, SLC7A5, SLC39A3 MEN1 1112/4885KMT2A 3082/4885CYP2C19 3657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.